Filter by input type
Select all
News
Pages
Events
Filter by category
Select all
AI ANALYTICS
Mobile Apps and Internet of Things
Advancement of science
big data
Connected communities
Coronavirus
Courses and training
DIAGNOSIS
Initial Editorial
Editorials
A world in the cloud
Events
Infographics
Artificial Intelligence and Science
IoT Apps
News
Digital platforms
Social networks
Review of scientific publications
Course Summary
Synopsis of essay
Overview of reference frames
Synopsis of recent publications
Use of Digital Platforms
Filter by input type
Select all
News
Pages
Events
Filter by category
Select all
AI ANALYTICS
Mobile Apps and Internet of Things
Advancement of science
big data
Connected communities
Coronavirus
Courses and training
DIAGNOSIS
Initial Editorial
Editorials
A world in the cloud
Events
Infographics
Artificial Intelligence and Science
IoT Apps
News
Digital platforms
Social networks
Review of scientific publications
Course Summary
Synopsis of essay
Overview of reference frames
Synopsis of recent publications
Use of Digital Platforms
MIT researchers develop AI system to detect errors in self-administered treatments

MIT researchers developed an Artificial Intelligence (AI) device to detect errors in the self-administration of medical treatments, such as the application of insulin or the use of inhalers.

Poor self-administration of medical treatment is a real public health problem that can cause serious health problems in patients, such as hospitalizations. However, it can be prevented through proper adherence to treatment by patients. MIT researchers developed a system that uses Artificial Intelligence to avoid this kind of situations in the self-administration of drugs specifically through devices such as inhalers or insulin pens.

The study “Assessment of medication self-administration using artificial intelligence”, published in Nature details that: “Errors in medication self-administration (MSA) lead to poor treatment adherence, increased hospitalizations and higher healthcare costs”.

These errors are particularly common when they involve the use of inhalers or insulin pens. That's why MIT researchers presented a non-contact AI model that achieves MSA error detection and monitoring.

“The system was developed by observing self-administration conducted by volunteers and evaluated by comparing its prediction with human annotations. Findings from this study demonstrate that our approach can automatically detect when patients use their inhalers (area under the curve (AUC) = 0.992) or insulin pens (AUC = 0.967), and assess whether patients follow the appropriate steps for using these devices (AUC = 0.952),” the study explains.

The model combines wireless technology and AI, and can be installed at home in the shape of a sensor to alert not only patients and their relatives, but also their physician, about possible medication errors. In this way they seek to reduce avoidable hospitalizations.

The system works as described below. First, the sensor tracks the patient's movements within a radius of approximately 10 meters, then the AI tracks the signs to distinguish whether the patient is using an insulin pen or an inhaler. Finally, the system alerts the patient and the medical professional when it has detected an error in the patient's self-administration.

The system has been tested and validated through a large set of more than 47,000 examples of self-administration events in 107 participants. In addition, the study used different physical environments, such as offices, living rooms, kitchens, hallways to measure the tool.

You can learn more about the results by reading the full article through the following link: https://www.nature.com/articles/s41591-021-01273-1

Outstanding news

News by country

Share

Digital Health in the world

  • — Science Brief: Omicron (B.1.1.529) Variant/CDC updates
    See more
  • —Coronavirus resource center/Johns Hopkins
    See more
  • — Epidemiological tracing of COVID-19 contacts / Johns Hopkins Course
    See more
  • — SARS-CoV-2 infection behavior / FCS calculator
    See more
  • — Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic/ Article The Lancet
    See more
  • —Genomic Epidemiology Tracker/GISAID
    See more
  • — Mexican Genomic Surveillance Consortium
    See more
Secured By miniOrange